Sustained cardioprotection: exploring unconventional modalities (Q37233509)

19 August 2017

1 reference

title

Sustained cardioprotection: exploring unconventional modalities (English)

1 reference

19 August 2017

Jason N Peart

1

1 reference

PubMed ID

18675381

19 August 2017

John P Headrick

series ordinal

2

1 reference

19 August 2017

13 July 2008

1 reference

19 August 2017

Vascular Pharmacology

1 reference

19 August 2017

49

1 reference

19 August 2017

2-3

1 reference

19 August 2017

63-70

1 reference

Preconditioning does not prevent postischemic dysfunction in aging heart

19 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Cardioprotective effect of ischemic preconditioning is preserved in food-restricted senescent rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Tandem action of exercise training and food restriction completely preserves ischemic preconditioning in the aging heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Exercise-induced activation of cardiac sympathetic nerve triggers cardioprotection via redox-sensitive activation of eNOS and upregulation of iNOS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of Gbetagamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Opioids: cellular mechanisms of tolerance and physical dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

The fibroblast growth factor receptor is at the site of convergence between mu-opioid receptor and growth factor signaling pathways in rat C6 glioma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Inhibition of Ras-GTPase, but not tyrosine kinases or Ca2+/calmodulin-dependent protein kinase II, improves recovery of cardiac function in the globally ischemic heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Signal transduction mechanisms involved in cardiac preconditioning: role of Ras-GTPase, Ca2+/calmodulin-dependent protein kinase II and epidermal growth factor receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Myocardial protection at a crossroads: the need for translation into clinical therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Cardioprotection afforded by chronic exercise is mediated by the sarcolemmal, and not the mitochondrial, isoform of the KATP channel in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Molecular mechanisms of life- and health-span extension: role of calorie restriction and exercise intervention.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

A1 adenosine receptor overexpression decreases stunning from anoxia-reoxygenation: role of the mitochondrial K(ATP) channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Ischemic preconditioning: from adenosine receptor to KATP channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Prolonging the delayed phase of myocardial protection: repetitive adenosine A1 receptor activation maintains rabbit myocardium in a preconditioned state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

H11 kinase prevents myocardial infarction by preemptive preconditioning of the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Exercise enhances myocardial ischemic tolerance via an opioid receptor-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Signaling pathways in ischemic preconditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Ischemic preconditioning is lost in aging hypertensive rat heart: independent effects of aging and longstanding hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Aging reduces the cardioprotective effect of ischemic preconditioning in the rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Preservation of heat stress induced myocardial hsp 72 in aged animals following caloric restriction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Recovery of trout myocardial function following anoxia: preconditioning in a non-mammalian model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Mechanism of decreased adenosine protection in reperfusion injury of aging rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

The end-effectors of preconditioning protection against myocardial cell death secondary to ischemia-reperfusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Preconditioning the human myocardium by simulated ischemia: studies on the early and delayed protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Post-opioid receptor adaptations to chronic morphine; altered functionality and associations of signaling molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: role of matrix metalloproteinase-2 inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

K(ATP) opener-induced delayed cardioprotection: involvement of sarcolemmal and mitochondrial K(ATP) channels, free radicals and MEK1/2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Extending the cardioprotective window using a novel delta-opioid agonist fentanyl isothiocyanate via the PI3-kinase pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

GSK3beta inhibition and K(ATP) channel opening mediate acute opioid-induced cardioprotection at reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Delayed cardioprotection afforded by the glycogen synthase kinase 3 inhibitor SB-216763 occurs via a KATP- and MPTP-dependent mechanism at reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Role of opioids in acute and delayed preconditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

The role of mitochondria in protection of the heart by preconditioning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Short-term exercise training can improve myocardial tolerance to I/R without elevation in heat shock proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Survival kinases in ischemic preconditioning and postconditioning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Preconditioning and postconditioning: united at reperfusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Ischaemic tolerance in aged mouse myocardium: the role of adenosine and effects of A1 adenosine receptor overexpression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Anesthetic-induced alteration in expression of myocardial calcium cycling proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Effect of acetylsalicylic acid on nuclear factor-kappaB activation and on late preconditioning against infarction in the myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Exercise and hormesis: activation of cellular antioxidant signaling pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

The role of opioid receptor phosphorylation and trafficking in adaptations to persistent opioid treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Volatile anesthetics evoke prolonged changes in the proteome of the left ventricule myocardium: defining a molecular basis of cardioprotection?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Fibroblast growth factor-2 and cardioprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Cardiac protection during acute myocardial infarction: where do we stand in 2004?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Postconditioning markedly attenuates ventricular arrhythmias after ischemia-reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Role of oxidative stress in PKC-delta upregulation and cardioprotection induced by chronic intermittent hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Aged rat myocardium exhibits normal adenosine receptor-mediated bradycardia and coronary vasodilation but increased adenosine agonist-mediated cardioprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Protein kinase C protects preconditioned rabbit hearts by increasing sensitivity of adenosine A2b-dependent signaling during early reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Sustained exogenous administration of Met5-enkephalin protects against infarction in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Long-term infusion of Met5-enkephalin fails to protect murine hearts against ischemia-reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Rho-kinase inhibition in the therapy of cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Chronic Angiotensin II Receptor Blockade Induces Cardioprotection During Ischemia by Increased PKC-ϵ Expression in the Mouse Heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Loss of exercise-induced cardioprotection after cessation of exercise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Exercise and myocardial tolerance to ischaemia-reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Gene therapy with iNOS provides long-term protection against myocardial infarction without adverse functional consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Rho kinase (ROCK) inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Caloric restriction restores the cardioprotective effect of preconditioning in the rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

The aging human myocardium: tolerance to ischemia and responsiveness to ischemic preconditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

The effect of gliclazide and glibenclamide on preconditioning of the human myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Hormesis and the antiaging action of dietary restriction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Overview of caloric restriction and ageing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Cardioprotective mechanism of ischemic preconditioning is impaired by postinfarct ventricular remodeling through angiotensin II type 1 receptor activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Longevity and aging: beneficial effects of exposure to mild stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Antioxidants and ecto-5'-nucleotidase are not involved in the training-induced cardioprotection against ischaemia-reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Exercise capacity and mortality among men referred for exercise testing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Cardioprotective effects of chronic hypoxia and ischaemic preconditioning are not additive

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Effects of mitochondrial K(ATP) modulators on cardioprotection induced by chronic high altitude hypoxia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Tolerance to ischaemia and ischaemic preconditioning in neonatal rat heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Effects of Glycogen Synthase Kinase 3beta and Cyclin-Dependent Kinase 5 Inhibitors on Morphine-Induced Analgesia and Tolerance in Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Sarcolemmal K(ATP) channel triggers opioid-induced delayed cardioprotection in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Sarcolemmal KATP channel triggers delayed ischemic preconditioning in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Adenosine and opioid receptor-mediated cardioprotection in the rat: evidence for cross-talk between receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Morphine-tolerant mice exhibit a profound and persistent cardioprotective phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Chronic exposure to morphine produces a marked cardioprotective phenotype in aged mouse hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Cardioprotective effects of acute and chronic opioid treatment are mediated via different signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Impaired p38 MAPK/HSP27 signaling underlies aging-related failure in opioid-mediated cardioprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Exercise-induced cardioprotection against myocardial ischemia-reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

In vitro platelet responsiveness to adenosine-mediated "preconditioning" is age-dependent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Exercise-induced HSP-72 elevation and cardioprotection against infarct and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Aging, anti-aging, and hormesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Ischemic preconditioning and preinfarction angina in the clinical arena

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Ischemia and ischemic preconditioning in the buffer-perfused pigeon heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Effect of aging on the ability of preconditioning to protect rat hearts from ischemia-reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Short-term caloric restriction improves ischemic tolerance independent of opening of ATP-sensitive K+ channels in both young and aged hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Cardioprotective effects of short-term caloric restriction are mediated by adiponectin via activation of AMP-activated protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Toward a unified theory of caloric restriction and longevity regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Endogenous adenosine protects preconditioned heart during early minutes of reperfusion by activating Akt.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

In vivo chronic carvedilol treatment in rats attenuates ex vivo regional infarction of the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Exercise-induced cardioprotection: endogenous mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Delayed adaptation of the heart to stress: late preconditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Drug-induced delayed cardiac protection against the effects of myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

The loss of pacing-induced preconditioning in atherosclerotic rabbits: role of hypercholesterolaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Improved postischemic function following acute exercise is not mediated by nitric oxide synthase in the rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

The anti-infarct effect of an adenosine A1-selective agonist is diminished after prolonged infusion as is the cardioprotective effect of ischaemic preconditioning in rabbit heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Sustained preconditioning induced by cardiac transgenesis with the tetracycline transactivator.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Molecular mechanisms of excitatory signaling upon chronic opioid agonist treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Converging protein kinase pathways mediate adenylyl cyclase superactivation upon chronic delta-opioid agonist treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Lack of adenosine causes myocardial refractoriness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Preconditioning in isolated superfused human muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Chronic preconditioning: a novel approach for cardiac protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Attenuated cardioprotection by ischemic preconditioning in coronary stenosed heart and its restoration by carvedilol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Adenosine-mediated cardioprotection in the aging myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Chronic morphine treatment reduces the incidence of ventricular arrhythmias in the isolated rat heart induced by dynorphin1-13 or myocardial ischemia and reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Exercise directly enhances myocardial tolerance to ischaemia-reperfusion injury in the rat through a protein kinase C mediated mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

Long-term aerobic exercise protects the heart against ischemia/reperfusion injury via PI3 kinase-dependent and Akt-mediated mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.07.001

10.1016/J.VPH.2008.07.001

7 January 2021

Identifiers

DOI

1 reference

release_p6zccvuw3nglbizhtbkdns3gr4

19 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/p6zccvuw3nglbizhtbkdns3gr4

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

18675381

1 reference

PubMed ID

18675381